• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探讨药物相关问题编码系统的基本原则:以PI-Doc为例。

Discussing basic principles for a coding system of drug-related problems: the case of PI-Doc.

作者信息

Schaefer Marion

机构信息

Institute of Pharmacy at Humboldt University, Goethestrasse 54, D-13086 Berlin, Germany.

出版信息

Pharm World Sci. 2002 Aug;24(4):120-7. doi: 10.1023/a:1019543029936.

DOI:10.1023/a:1019543029936
PMID:12227243
Abstract

Coding systems are important tools for the documentation of drug-related problems and following interventions. They should be suitable not only for scientific studies but for the broader implementation of Pharmaceutical Care in the pharmacy. A suitable coding system must be easy to use in daily routine. To facilitate later computer aided use, it should be preferably structured like a decision tree and consist of three parts: 1. the classification of drug-related problems 2. the intervention taken to solve to problem 3. the degree to which the problem was solved. PI-Doc considers other classification systems used by Hepler and Strand the PAS-Coding System and draws empirical experience from a study in 1995 and 1998 in Germany. The main groups comprise the following: unsuitable drug choice unsuitable use by the patient, incl. compliance unsuitable dosage drug-drug interactions adverse drug reactions other drug-related problems patient-related communication-related technical and logistic problems. The article discusses basic principles of the development of a coding system and the prerequisites for its application. In addition, it tries to give guidance for the classification process itself. It is also recommended to collect further information while documenting drug-related problems, in order to allow additional statistical evaluation.

摘要

编码系统是记录药物相关问题及后续干预措施的重要工具。它们不仅应适用于科学研究,还应适用于药房药学服务的更广泛实施。合适的编码系统必须便于日常使用。为便于日后计算机辅助使用,它最好应像决策树一样结构化,并由三部分组成:1. 药物相关问题的分类;2. 为解决问题采取的干预措施;3. 问题解决的程度。PI-Doc参考了赫普勒和斯特兰德使用的其他分类系统(PAS编码系统),并借鉴了1995年和1998年在德国进行的一项研究的经验。主要类别包括:药物选择不当、患者使用不当(包括依从性)、剂量不当、药物相互作用、药物不良反应、其他药物相关问题、与患者相关的沟通相关技术和后勤问题。本文讨论了编码系统开发的基本原则及其应用的前提条件。此外,它还试图为分类过程本身提供指导。还建议在记录药物相关问题时收集更多信息,以便进行额外的统计评估。

相似文献

1
Discussing basic principles for a coding system of drug-related problems: the case of PI-Doc.探讨药物相关问题编码系统的基本原则:以PI-Doc为例。
Pharm World Sci. 2002 Aug;24(4):120-7. doi: 10.1023/a:1019543029936.
2
Analysis of drug-related problems in three departments of a German University hospital.德国一家大学医院三个科室的药物相关问题分析。
Int J Clin Pharm. 2016 Feb;38(1):119-26. doi: 10.1007/s11096-015-0213-1. Epub 2015 Oct 28.
3
Development of a classification system for drug-related problems in the hospital setting (APS-Doc) and assessment of the inter-rater reliability.开发一种医院环境下药物相关问题的分类系统(APS-Doc)并评估其评分者间信度。
J Clin Pharm Ther. 2012 Jun;37(3):276-81. doi: 10.1111/j.1365-2710.2011.01281.x. Epub 2011 Jul 26.
4
Development and validation of the Slovenian drug-related problem classification system based on the PCNE classification V 6.2.基于PCNE分类V 6.2的斯洛文尼亚药物相关问题分类系统的开发与验证
Int J Clin Pharm. 2016 Aug;38(4):950-9. doi: 10.1007/s11096-016-0320-7. Epub 2016 Jun 2.
5
A primer of drug safety surveillance: an industry perspective. Part II: Product labeling and product knowledge.药物安全监测入门:行业视角。第二部分:产品标签与产品知识。
J Pharm Technol. 1992 Sep-Oct;8(5):198-202. doi: 10.1177/875512259200800508.
6
[Systematic drug documentation].
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2005 Jul;48(7):736-41. doi: 10.1007/s00103-005-1072-z.
7
[The German Medical Devices Information System containing over 100,000 documents].[包含超过10万份文档的德国医疗器械信息系统]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2009 Jun;52(6):625-34. doi: 10.1007/s00103-009-0850-4.
8
Therapeutic drug monitoring databases for postmarketing surveillance of drug-drug interactions.用于药物相互作用上市后监测的治疗药物监测数据库。
Drug Saf. 2001;24(13):947-59. doi: 10.2165/00002018-200124130-00002.
9
[Surveillance and assessment of undesirable effects in drug treatment: pilot project].
Soz Praventivmed. 1989;34(6):272-7. doi: 10.1007/BF02083222.
10
EPICC study: evaluation of pharmaceutical intervention in cancer care.EPICC研究:癌症护理中药物干预的评估。
J Clin Pharm Ther. 2015 Apr;40(2):196-203. doi: 10.1111/jcpt.12242. Epub 2015 Jan 16.

引用本文的文献

1
Identification, classification, and documentation of drug related problems in community pharmacy practice in Europe: a scoping review.欧洲社区药房实践中药物相关问题的识别、分类与记录:一项范围综述
Int J Clin Pharm. 2025 Apr;47(2):247-269. doi: 10.1007/s11096-024-01834-7. Epub 2025 Jan 8.
2
Reduced prevalence of drug-related problems in psychiatric inpatients after implementation of a pharmacist-supported computerized physician order entry system - a retrospective cohort study.实施药剂师支持的计算机化医嘱录入系统后精神科住院患者药物相关问题的患病率降低——一项回顾性队列研究
Front Psychiatry. 2024 Apr 9;15:1304844. doi: 10.3389/fpsyt.2024.1304844. eCollection 2024.
3

本文引用的文献

1
An ABC of drug-related problems.药物相关问题入门
Drug Saf. 2000 Jun;22(6):415-23. doi: 10.2165/00002018-200022060-00001.
2
Factors influencing the detection rate of drug-related problems in community pharmacy.影响社区药房药物相关问题检出率的因素。
Pharm World Sci. 1999 Dec;21(6):245-50. doi: 10.1023/a:1008767406692.
3
Pharmacist's management of drug-related problems: a tool for teaching and providing pharmaceutical care.药剂师对药物相关问题的管理:一种教学和提供药学服务的工具。
Development and partial validation of Be-CLIPSS: a classification system for hospital clinical pharmacy activities.
Be-CLIPSS 的制定与部分验证:一种医院临床药学活动的分类系统。
Int J Clin Pharm. 2024 Feb;46(1):80-89. doi: 10.1007/s11096-023-01627-4. Epub 2023 Sep 1.
4
Validation of an assessment, medical problem-oriented plan, and care plan tools for demonstrating the clinical pharmacist's activities.用于展示临床药师活动的评估、以医疗问题为导向的计划和护理计划工具的验证。
Saudi Pharm J. 2022 Oct;30(10):1464-1472. doi: 10.1016/j.jsps.2022.07.007. Epub 2022 Jul 25.
5
Impact of a Collaborative Pharmaceutical Care Service for Patients With Parkinson's Disease.一项针对帕金森病患者的协作药学服务的影响
Front Pharmacol. 2022 Jan 3;12:793361. doi: 10.3389/fphar.2021.793361. eCollection 2021.
6
Prevalence and risk factors of drug-related problems identified in pharmacy-based medication reviews.基于药学的药物使用审查中发现的药物相关问题的流行率及风险因素。
Int J Clin Pharm. 2020 Apr;42(2):588-597. doi: 10.1007/s11096-020-00976-8. Epub 2020 Feb 5.
7
Clinical Pharmacy Activities Documented (ClinPhADoc): Development, Reliability and Acceptability of a Documentation Tool for Community Pharmacists.临床药学活动记录(ClinPhADoc):一种社区药剂师记录工具的开发、可靠性和可接受性
Pharmacy (Basel). 2019 Dec 2;7(4):162. doi: 10.3390/pharmacy7040162.
8
Prospective survey-based study on the categorization quality of hospital pharmacists' interventions using DokuPIK.基于前瞻性调查的关于使用DokuPIK对医院药师干预措施进行分类质量的研究。
Int J Clin Pharm. 2019 Apr;41(2):414-423. doi: 10.1007/s11096-019-00785-8. Epub 2019 Mar 20.
9
Adaptation and validation of PCNE drug-related problem classification v6.2 in French-speaking Belgian community pharmacies.PCNE药物相关问题分类v6.2在比利时法语区社区药房的改编与验证
Int J Clin Pharm. 2019 Feb;41(1):244-250. doi: 10.1007/s11096-018-0773-y. Epub 2019 Jan 4.
10
Impact of a commercial order entry system on prescribing errors amenable to computerised decision support in the hospital setting: a prospective pre-post study.商业医嘱录入系统对医院环境中可通过计算机决策支持纠正的处方错误的影响:一项前瞻性前后研究。
BMJ Qual Saf. 2018 Sep;27(9):725-736. doi: 10.1136/bmjqs-2017-007135. Epub 2018 Mar 23.
Pharmacotherapy. 1997 Jul-Aug;17(4):801-9.
4
The Electronic Pharmaceutical Dossier: an effective aid to documenting pharmaceutical care data.电子药品档案:记录药学服务数据的有效辅助工具。
Pharm World Sci. 1996 Dec;18(6):241-3. doi: 10.1007/BF00735967.
5
Improved detection of drug-related problems in intensive care unit patients.重症监护病房患者中与药物相关问题的检测得到改善。
Am J Health Syst Pharm. 1996 Jan 15;53(2):185-6. doi: 10.1093/ajhp/53.2.185a.
6
Drug-related problems: their structure and function.药物相关问题:其结构与功能。
DICP. 1990 Nov;24(11):1093-7. doi: 10.1177/106002809002401114.